Pulmonary Diffusing Capacity for Nitric Oxide¶

A pulmonary-function measure of nitric-oxide uptake from alveolar gas into pulmonary capillary blood, weighted toward alveolar–capillary membrane conductance and often paired with carbon-monoxide diffusing capacity to partition gas-transfer resistance.

Version: v1 · 2026-09-28 · History
Domain-specific #: 7736
Domain group: Applied Sciences & Engineering
Origin domain: Medicine & Healthcare
Subdomain: Pulmonary Function Testing → Medicine & Healthcare
Aliases: DLNO, D L,NO, TLNO, T L,NO, Transfer Factor of the Lung for Nitric Oxide

Core Idea¶

Pulmonary Diffusing Capacity for Nitric Oxide, abbreviated DLNO or TLNO, quantifies how rapidly inhaled nitric oxide moves from alveolar gas into pulmonary capillary blood per unit driving pressure.^[1] Because nitric oxide reacts with hemoglobin far more rapidly than carbon monoxide, its measured uptake is comparatively weighted toward conductance across the alveolar–capillary membrane.^[2] The measure is therefore useful both as a standardized pulmonary-function result and, when obtained with DLCO, as evidence for partitioning membrane and blood components of lung gas transfer.^[3]

The abstraction is a measurement relation, not a disease or anatomical part. A controlled inspired mixture, breath maneuver, gas analysis, pressure convention, and physiological model transform concentration change into a conductance-like quantity. Interpretation depends on declared units, reference equations, quality control, and assumptions about hemoglobin reaction and pulmonary capillary blood volume.^[4]

Structural Signature¶

Sig role-phrases:

Test subject and lung volume — the assessed respiratory system and alveolar volume over which nitric-oxide transfer is measured.^[5]
NO-bearing test gas — the controlled inspired mixture containing nitric oxide and the gases needed for the single-breath determination.
Standardized breath maneuver — inspiration, breath hold, washout, alveolar sampling, and recovery performed under declared timing and acceptability rules.
Calibrated gas analysis — paired inspired and expired concentration measurements from which nitric-oxide disappearance is obtained.
Transfer model — the effective alveolar-to-blood pressure difference and physiological assumptions that convert uptake into conductance.
DLNO result — nitric-oxide transfer rate per unit driving pressure, reported in declared conventional or SI units.^[6]
Differential partition — paired DLNO and DLCO weight membrane and blood-phase resistance differently, permitting a model-dependent component split.
Validity envelope — device, calibration, maneuver quality, hemoglobin and altitude corrections, and reference equations bound comparison and interpretation; concentration monitoring alone is not DLNO.

What It Is Not¶

Not DLCO. Carbon monoxide transfer is more influenced by red-cell reaction and pulmonary capillary blood volume, whereas nitric oxide uptake comparatively weights alveolar–capillary membrane conductance; paired testing can use this contrast.^[7]
Not exhaled-nitric-oxide measurement for airway inflammation. That test measures endogenous NO in expired gas, while DLNO measures disappearance of a controlled inspired tracer across the lung–blood barrier.
Not nitric-oxide toxicity or exposure monitoring. The standardized test uses a declared low-concentration mixture and breath maneuver to estimate transfer conductance rather than to assess hazardous dose.
Not arterial oxygenation or a shunt equation. Oxygen saturation, blood gases, ventilation–perfusion relations, and shunt answer different physiological questions from tracer uptake per unit driving pressure.
Not a direct image of alveolar structure. The result is a model-dependent conductance-like quantity shaped by membrane, capillary blood, alveolar volume, gas analysis, and maneuver quality.
Not a diagnosis of one disease. Emphysematous, interstitial, vascular, hematologic, and technical factors can alter DLNO, so interpretation requires reference equations and companion evidence.^[8]
Not comparable without a protocol envelope. Units, device calibration, inspired mixture, timing, sample acceptance, altitude, hemoglobin assumptions, and reference population must be declared.

Scope of Application¶

DLNO applies wherever a standardized pulmonary-function maneuver measures disappearance of inhaled nitric oxide from alveolar gas and reports uptake per effective pressure difference under a declared protocol and reference system.^[9] Literal use requires the pulmonary carrier, NO-bearing test gas, calibrated analyzer, acceptable breath maneuver, units, and physiological model; endogenous exhaled NO, exposure monitoring, or an unstandardized concentration change is outside the scope.

Clinical pulmonary-function laboratories. DLNO can accompany routine gas-transfer assessment when approved equipment, trained operators, quality control, and an applicable reference equation are available.
Respiratory-physiology laboratories. Controlled studies use the measurement to investigate alveolar-to-capillary gas transfer and its membrane and blood-phase contributions.
Combined single-breath DLNO–DLCO testing. Simultaneous nitric-oxide and carbon-monoxide uptake permits direct reporting of both capacities and their ratio from one maneuver.
Membrane–microvascular partition studies. Paired measurements support model-dependent estimates of membrane diffusing capacity and pulmonary capillary blood volume under declared Roughton–Forster assumptions.^[10]
Time-based diffusion–reaction studies. DLNO also supplies observations for models that distinguish membrane–plasma transit, red-cell surface capture, and intracellular reaction time rather than assuming strictly separable serial resistances.
Healthy-population reference studies. Standardized testing in healthy participants establishes predicted values, lower limits of normal, z-scores, and the effects of age, body size, sex, device, ancestry, and altitude.
Pediatric-through-older-adult assessment. Device-specific reference work spans childhood through advanced age when age-phase equations and an appropriate comparison population are used.
Longitudinal and repeat testing. Within-session repeatability and week-to-week or month-to-month change can be evaluated when maneuver timing, analyzer, reference system, and quality thresholds remain compatible.
Exercise physiology. DLNO measurements track the increase in pulmonary transfer capacity with exercise under controlled testing conditions.
Altitude physiology. Tests in newcomers and habitual residents examine how altitude changes DLNO and why altitude must be represented in reference interpretation.
Diving and hyperoxic exposure studies. Controlled measurements assess reduced gas-transfer capacity after diving or oxygen breathing without turning DLNO into an exposure-dose measure.
Pulmonary vascular disease assessment. DLNO, DLCO, and their ratio are studied in pulmonary arterial hypertension and hepatopulmonary syndrome for patterns weighted toward microvascular impairment.
Interstitial and diffuse parenchymal lung disease. Paired transfer measurements investigate membrane-dominant, vascular-dominant, or mixed impairment while retaining technique- and stage-dependent uncertainty.
Smoking-related obstruction and emphysema studies. DLNO is used alongside spirometry, lung volumes, and DLCO to assess early vascular change, established COPD, and emphysematous membrane loss.
Heart-failure assessment. Combined DLNO and DLCO z-scores can contribute complementary pulmonary-transfer information in cardiopulmonary classification models.
Post-COVID-19 lung assessment. Multicenter testing uses DLNO with DLCO, spirometry, and lung volumes to characterize persistent gas-transfer impairment after infection.
Other systemic and pulmonary conditions. Studies include cystic fibrosis, chronic renal failure, morbid obesity, and follow-up after bone-marrow transplantation, with condition-specific interpretation rather than a single-disease threshold.
Analyzer and device-comparison studies. Chemiluminescence, electrochemical, and other NO systems are compared for response time, sensitivity, calibration, breath-hold protocol, and device-specific bias.
Multicenter harmonization and global reference development. Shared quality-assurance protocols and pooled datasets extend the measure only when device, altitude, breath-hold time, hemoglobin, body size, age, sex, ancestry, and reporting conventions are retained.

Clarity¶

A clear report states whether the symbol means diffusing capacity or transfer factor, gives conventional or SI units, names the technical standard, and distinguishes measured quantities from modeled components. A low DLNO is an observation; attributing it specifically to membrane thickening requires additional evidence.

Joint interpretation should state the assumed NO–hemoglobin reaction rate and any fixed ratio used to solve for membrane conductance and capillary blood volume. Precision should not exceed what the maneuver and model support.

Manages Complexity¶

DLNO compresses a rapid multistep path—ventilation, alveolar mixing, membrane transfer, plasma diffusion, and hemoglobin reaction—into uptake per effective alveolar-to-blood pressure difference. The analyst tracks the maneuver and breath-hold time, inspired and expired concentrations, alveolar volume, analyzer and calibration, units, hemoglobin and altitude corrections, and reference equation. Those coordinates make a result readable as within or below its reference range and comparable across repeated tests when protocol and device remain compatible.

Paired DLNO and DLCO add a second regime because the gases weight membrane and blood-phase resistance differently; their values and ratio can constrain whether observed loss is more consistent with membrane-dominant, microvascular-dominant, or mixed impairment under the declared partition model. The compression stops short of unique anatomy or diagnosis. Uneven ventilation and perfusion, leaks, submaximal inspiration, analyzer dynamics, device-specific bias, and uncertain reaction kinetics can produce the same derived pattern, while any membrane-conductance or capillary-volume split remains model-dependent rather than directly measured.

Abstract Reasoning¶

Reasoning begins with resistances in series. Overall gas transfer reflects membrane and blood components, but nitric oxide and carbon monoxide weight those components differently. Two suitably independent measurements can therefore constrain otherwise entangled physiological contributions.

A valid counterfactual asks which component should alter DLNO more than DLCO, while recognizing that real disease may change several components simultaneously. The measurement supports decomposition; it does not guarantee unique causal inference.

Knowledge Transfer¶

Within respiratory physiology and pulmonary-function testing, DLNO transfers literally across laboratories, reference-population studies, exercise protocols, longitudinal testing, and investigations of membrane or pulmonary microvascular impairment when the maneuver, calibration, units, corrections, and interpretive model remain compatible. What carries is uptake per effective alveolar-to-blood pressure difference, together with the breath-hold and concentration measurements, acceptability criteria, alveolar-volume context, hemoglobin and altitude corrections, and the distinction between the observed DLNO and any modeled membrane or capillary-blood component. The paired DLNO–DLCO vocabulary and resistance-in-series model license diagnostics for leaks, uneven ventilation, device bias, poor inspiration, and assumption-sensitive partitioning; interventions include repeating an unacceptable maneuver, standardizing equipment, matching reference equations, or reporting only the measured capacity when causal decomposition is underdetermined.

Beyond this home domain, the honest reach is principally C — instrument or measure, with a limited B — shared abstract mechanism. DLNO itself travels literally only wherever the same pulmonary carrier, nitric-oxide uptake procedure, units, and physiological preconditions hold; it cannot be exported as a generic transport coefficient. Through Measurement, other tracer methods can reuse the broader structure of operationalizing a quantity under a declared model, and differential probes can share the tactic of weighting latent resistances differently so joint observations constrain their contributions. Nitric oxide, alveoli, capillary blood, hemoglobin kinetics, DLCO ratios, and pulmonary reference equations remain home-bound. Transfer stops before the joint-gas model is assumed to identify a unique lesion, or before similarity in a two-probe decomposition licenses the name DLNO outside lung gas exchange.

Examples¶

Canonical¶

In a pulmonary-function laboratory, an assessed person completes the standardized single-breath maneuver with a controlled test mixture containing nitric oxide and carbon monoxide. Calibrated analyzers compare inspired and alveolar-sample concentrations, and the declared model converts nitric-oxide disappearance into uptake per effective alveolar-to-blood pressure difference. The report gives DLNO in stated units together with lung volume, maneuver-quality indicators, device, reference equation, and relevant corrections. Paired DLCO is reported separately so their differing membrane and blood-phase sensitivities can support, but not uniquely determine, a component partition.

Mapped back: The assessed respiratory system supplies Test subject and lung volume, the mixture is the NO-bearing test gas, and the performed sequence is the Standardized breath maneuver. Inspired and expired readings provide Calibrated gas analysis, interpreted by the Transfer model as the DLNO result. Pairing it with DLCO permits the model-dependent Differential partition, while protocol and reporting qualifications define the Validity envelope.

Applied / In Practice¶

A multicenter reference study compares DLNO results from healthy participants measured on different analyzer systems. Investigators find that device, calibration, breath-hold convention, age, body size, sex, ancestry, and altitude can shift the comparison. They therefore derive and report device- and population-qualified reference equations rather than pool every number as interchangeable. When a later result is lower than its appropriate reference, it remains a gas-transfer measurement requiring other clinical and physiological evidence; it is not by itself a unique disease diagnosis.

Mapped back: Standardized participant measurements instantiate Test subject and lung volume, Standardized breath maneuver, Calibrated gas analysis, and DLNO result across sites. Device, calibration, corrections, and population equations are the Validity envelope that governs legitimate comparison. The final refusal to infer one disease directly from the measured capacity preserves the measurement's model-bound interpretation rather than adding a diagnostic claim not supplied by the Transfer model.

Structural Tensions¶

T1: Membrane weighting versus whole-lung dependence. Rapid nitric-oxide reaction with hemoglobin makes DLNO comparatively sensitive to alveolar–capillary membrane conductance, yet the measured result still depends on alveolar volume, ventilation distribution, capillary blood, analyzer behavior, and maneuver quality. “Membrane weighted” must not become “membrane only.”

Diagnostic: Which nonmembrane physiological and technical influences remain capable of producing the observed DLNO value?

T2: Standardized maneuver versus physiological realism. A controlled single-breath test makes results repeatable and comparable, while it samples gas transfer under a brief imposed breathing condition rather than every state of ordinary respiration. Standardization strengthens measurement by narrowing the state represented.

Diagnostic: Does the interpretation remain within the lung volume, timing, and maneuver conditions under which the capacity was obtained?

T3: Differential partitioning versus model dependence. Paired DLNO and DLCO weight membrane and blood-phase resistances differently, allowing a component split that one gas cannot support. The inferred membrane conductance and capillary blood volume nevertheless depend on reaction-rate and serial-resistance assumptions rather than being directly observed.

Diagnostic: How stable is the proposed partition under defensible alternatives for hemoglobin reaction and transfer-model parameters?

T4: Numerical precision versus maneuver repeatability. Gas analysis and equations can produce a highly resolved number, while leaks, submaximal inspiration, breath-hold timing, sampling, and device response limit reproducibility. Extra digits do not recover information that the maneuver failed to supply.

Diagnostic: Do acceptability, repeatability, device performance, and uncertainty support the precision used in the conclusion?

T5: Physiological sensitivity versus diagnostic specificity. DLNO can reveal altered pulmonary gas transfer, but membrane, microvascular, blood, lung-volume, and technical factors can yield similar changes. Sensitivity to impairment does not make the measure a unique disease label.

Diagnostic: Which companion measurements and model checks distinguish among plausible causes of the abnormal result?

T6: Cross-laboratory comparability versus protocol specificity. Shared technical standards support reference equations and longitudinal comparison, yet device, calibration, breath-hold convention, units, altitude, hemoglobin assumptions, and population references can shift results. Harmonization requires carrying the protocol envelope, not merely the symbol DLNO.

Diagnostic: Are the compared values traceable to compatible equipment, maneuver, corrections, units, and reference populations?

T7: Pulmonary Diffusing Capacity for Nitric Oxide autonomy versus reduction to Measurement (Measurement). The parent Prime carries the portable structure of assigning a quantity through observations, calibration, and a model. Every DLNO determination is a strict kind of Measurement because an observed nitric-oxide uptake is mapped to a pulmonary diffusing-capacity value under a standardized model, but the child fixes alveolar gas, pulmonary capillary blood, a breath maneuver, and lung-transfer assumptions. Reduction loses the physiological quantity; total autonomy hides the operational measurement structure.

Diagnostic: Does the account preserve the NO-specific pulmonary carrier and validity envelope as differentia of this Measurement?

Structural–Framed Character¶

Pulmonary Diffusing Capacity for Nitric Oxide is mixed-structural. Its vocab_travels is low because DLNO, alveolar sampling, membrane conductance, capillary blood, and paired DLCO interpretation are respiratory-physiology terms. Its evaluative_weight is substantial because acceptability, correction, reference equations, and clinical comparison depend on protocol, though gas uptake is physical. Its institutional_origin lies in standardized pulmonary-function testing. Its human_practice_bound is moderate: transfer occurs biologically, while the named measure requires a designed maneuver and model. On import_vs_recognize, concentration change is observed, but conductance, units, validity envelope, and component partition are constructed measurements.

The smallest reviewed portable skeleton is Measurement: a target attribute interacts with an instrument and procedure to yield a value on a declared scale under calibration, traceability, and uncertainty conditions. Portable and cross-domain reach belongs to that Prime. DLNO adds nitric-oxide test gas, alveolar-to-blood transfer, a standardized breath maneuver, calibrated gas analysis, lung volume, effective driving-pressure assumptions, and model-dependent pairing with carbon-monoxide capacity. Those physiological and protocol roles prevent reduction to Measurement alone.

Its character: mixed-structural because pulmonary gas transfer is physical, while the reported DLNO quantity is constituted by a standardized instrument–procedure–model frame.

Structural Core vs. Domain Accent¶

Pulmonary Diffusing Capacity for Nitric Oxide is domain-specific rather than a prime because its measurement chain targets nitric-oxide transfer across the pulmonary alveolar–capillary interface.

What is skeletal (could lift toward a cross-domain prime). The portable skeleton is the complete chain of Measurement: a target attribute is mapped onto a declared scale by an instrument and reproducible procedure, the result is anchored by units and calibration within an observer frame, and an uncertainty envelope bounds the value's use. That organization recurs literally in physical thermometry, economic indicator construction, and software benchmarking. Pulmonary Diffusing Capacity for Nitric Oxide is a strict domain-specific specialization rather than a prime because every link is fixed to nitric-oxide transfer across the alveolar–capillary interface.

What is domain-bound. Test subject and lung volume, NO-bearing test gas, Standardized breath maneuver, and Calibrated gas analysis provide the pulmonary carrier, procedure, and instrument path; the Transfer model converts observed disappearance into the DLNO result in declared units. A paired Differential partition with DLCO can weight membrane and blood-phase resistance differently, while the Validity envelope retains device, calibration, maneuver quality, lung volume, hemoglobin and altitude assumptions, reference equations, and model dependence. These physiological roles and interpretation limits are constitutive, and a DLNO value remains a measure rather than a disease diagnosis or direct anatomical image.

Why this does not clear the prime bar. The complete named signature does not recur literally across at least three unrelated domains: thermometers, economic indices, and software benchmarks instantiate Measurement but do not involve inhaled nitric oxide, alveolar gas, pulmonary capillary blood, or a DLNO–DLCO partition. Knowledge Transfer therefore classifies DLNO chiefly as a home-bound instrument/measure and assigns only the operational quantity and differential-probe strategy to broader Measurement. Removing pulmonary gas-transfer roles while retaining the attribute–scale–instrument–procedure–calibration–frame–uncertainty chain leaves Measurement, not DLNO; removing that measurement chain while retaining lung anatomy and nitric-oxide physiology leaves a physiological topic without a DLNO result and destroys the strict subsumption under Measurement.

This entry is a kind of Measurement.

Instantiates — Measurement (Measurement). The target attribute is nitric-oxide transfer from alveolar gas into pulmonary capillary blood; the scale is transfer rate per effective driving pressure in declared conventional or SI units. Calibrated gas analysis provides the instrument, and the standardized inspired mixture, breath maneuver, washout, alveolar sampling, and calculation model provide the procedure. Calibration, reference equations, lung volume, timing, hemoglobin and altitude assumptions, and an uncertainty and acceptability envelope supply the unit, frame, and traceability commitments, while the inhaled tracer makes the instrument–target interaction explicit rather than incidental. Removing pulmonary physiology and the nitric-oxide-specific protocol leaves the full attribute–instrument–procedure–scale Measurement signature; removing that chain leaves neither a DLNO value nor a defensible comparison.

Relationships to Other Abstractions¶

Current abstraction Pulmonary Diffusing Capacity for Nitric Oxide Domain-specific

Parents (1) — more general patterns this builds on

Pulmonary Diffusing Capacity for Nitric Oxide is a kind of Measurement Prime

The target attribute is nitric-oxide transfer from alveolar gas into pulmonary capillary blood; the scale is transfer rate per effective driving pressure in declared conventional or SI units.

Hierarchy path (1) — routes to 1 parentless root

Pulmonary Diffusing Capacity for Nitric Oxide → Measurement

Neighborhood in Abstraction Space¶

Pulmonary Diffusing Capacity for Nitric Oxide sits in a sparse region of the domain-specific corpus (89^th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Unclustered & Miscellaneous (2551 abstractions)

Nearest neighbors

Rapid Shallow Breathing Index — 0.82
Body Fluid to Serum Concentration Ratio — 0.82
Helium dilution technique — 0.81
Bronchoalveolar lavage — 0.80
Thyroid hormone binding ratio — 0.79

Computed from structural-signature embeddings · 2026-10-08

Not to Be Confused With¶

Diffusing Capacity for Carbon Monoxide. DLCO is a related tracer-gas conductance measure whose result reflects both membrane transfer and carbon monoxide's blood-phase reaction. Tell: the declared tracer and uptake model distinguish DLCO from nitric-oxide diffusing capacity even when both use similar breath measurements.
Fractional Exhaled Nitric Oxide. Fractional exhaled nitric oxide measures endogenous airway nitric oxide as an inflammation-related marker, whereas DLNO measures uptake of an administered tracer to estimate gas-transfer conductance. Tell: endogenous exhaled concentration identifies FeNO; disappearance of a known inspired tracer identifies DLNO.
Oxygen Saturation. Oxygen saturation reports the proportion of blood hemoglobin carrying oxygen, a downstream state affected by many processes. Tell: a blood-oxygen percentage is saturation; tracer uptake normalized by driving pressure is diffusing capacity.
Pulmonary Shunt. A pulmonary shunt is perfusion that bypasses ventilated gas exchange and can impair oxygenation without directly measuring alveolar–capillary conductance. Tell: blood flow through nonventilated regions identifies shunt; nitric-oxide transfer from alveolar gas into blood identifies DLNO.
Membrane Diffusing Capacity. Membrane diffusing capacity is a modeled component of total pulmonary transfer that joint tracer measurements may estimate, not the raw DLNO measurement itself. Tell: a model-derived membrane term is the component; the observed nitric-oxide uptake conductance is DLNO.

References¶

[1] Standardisation and Application of the Single-Breath Determination of Nitric Oxide Uptake in the Lung registry ↩ Show verification details

[2] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[3] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[4] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[5] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[6] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[7] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[8] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[9] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩

[10] Unverified encyclopedia synthesis; claim-specific authoritative support was not established in this verification pass. ↩